The Effect of CoQ Supplementation on Quality of Life in Women with Breast Cancer Undergoing Tamoxifen Therapy: A Double-Blind, Placebo-Controlled, Randomized Clinical Trial.

Clicks: 225
ID: 98120
2020
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #28 of 93 articles by views in Psychology research and behavior management

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Survival rates among breast cancer patients and the number of patients living with treatment side effects have improved, leading to increased focus on quality of life (QOL). The objective of this study was to determine the efficacy of CoQ on QOL scores among breast cancer patients in Iranian undergoing tamoxifen therapy.Thirty breast cancer patients were randomized into two groups. The first group received 100 mg CoQ, and the second group took fplacebo once a day for 8 weeks. QOL was evaluated by a standard QOL questionnaire and a specific questionnaire on QOL of breast cancer patients at baseline and the end of the study. Also, physical activity of patients was assessed with the IPAQ questionnaire and dietary intake determined by a 3-day dietary record.The data of 30 subjects were analyzed. According to QOL C30 data, CoQ led to a significant increase in physical functioning (=0.029), emotional functioning (=0.031), and cognitive functioning (=0.023) compared to placebo. Symptom scales revealed a notable reduction in appetite loss in the first group (=0.01). Global health status showed no significant changes in either study arm. On the QOL BR23, progress in functions and decline in symptoms were not statistically significant. Arm symptoms showed significant reduction (=0.022) in patients that received placebo.This trial indicates that CoQ supplementation has effects in ameliorating some dimensions of QOL in breast cancer patients. To generalize the results, larger and longer intervention studies are needed.IRCT2015042021874N1.
Reference Key
hosseini2020thepsychology Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Hosseini, Seyed Ahmad;Zahrooni, Nazanin;Ahmadzadeh, Ahmad;Ahmadiangali, Kambiz;Assarehzadegan, Mohammad-Ali;
Journal Psychology research and behavior management
Year 2020
DOI
10.2147/PRBM.S241431
URL
Keywords
Breast cancer CoQ10 quality of life tamoxifen

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.